CTRI/2022/01/039482尚未招募未知
Effectiveness of Curcumin in reducing the presence of Treponema denticola, Tannerella forsythia, Porphyromonas gingivalis in peri Implant area when used with Tissue Conditioner
Dr Akshitha H M0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •â??Patients with good oral hygiene undergoing 2 stage implant surgery
- •â??Patients with adequate bone height and width of at least 10mm and 6.5mm respectively.
排除标准
- •1. Patients who are smokers and chronic alcoholics.
- •2. Patients having undergone antibiotic therapy for preceding 6 weeks
- •3. Uncontrolled Diabetic (Hba1C above 7.5) and immunocompromised patients
- •4. Known allergy to tissue conditioner or curcumin
- •5. Patients needing bone augmentation procedures at the time of implant placement
- •6. Pregnancy and Lactation
研究者
相似试验
尚未招募
3 期
Evaluation of the effect of curcumin in the prevention of vancomycin-induced nephrotoxicity in patients hospitalized in the intensive care unit of Kosar Hospital, Semnan: a randomized, double-blinded, placebo-controlled clinical trialIRCT20240501061620N1Semnan University of Medical Sciences70
已完成
3 期
Effect of Curcumin in Treatment of Pediatric Intractable EpilepsyPediatric intractable epilepsy.Epilepsy, unspecified, intractable, without status epilepticusG40.919IRCT20130811014330N7Mashhad University of Medical Sciences22
已完成
3 期
Efficacy and mechanism of curcumin in prevention and treatment of diabetes, liver cirrhosis from nonalcoholic fatty liver disease (NAFLD), and osteoporosis in the patients with type 2 diabetescurcuminoids extracttype 2 diabetesinsulin resistanceobesityfatty liverosteoporosiscurcuminoids extracttype 2 diabetesfatty liverinsulin resistanceobesityosteoporosisTCTR20140303003Thailand Research Fund296
招募中
3 期
Investigation of the Effect of Curcumin in preventing complications of chemotherapyIRCT20190224042818N1Mashhad University of Medical Sciences40
尚未招募
3 期
Effect of curcumin on the prevention of contrast induced nephropathyephropathy induced by contrast agents.Nephropathy induced by other drugs, medicaments and biological substancesN14.1IRCT20210413050958N2Mashhad University of Medical Sciences227